[7] AHMED H U, EL-SHATER BOSAILY A, BROWN L C, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study[J]. Lancet, 2017, 389(10...
Especially for PI-RADS > 3 lesions, detection of csPCa can be improved by increasing the number of MRI-targeted biopsy cores [28]. A study of van der Leest found that, when MRI-guided biopsy of prostate lesions is performed, “local saturation” by an additional four perilesional ...
MRI Improves Prostate Cancer Biopsy Accuracy, Study Finds; New Technology Spots More Aggressive Cancer, but Fewer Low-Risk CasesThompson, Dennis
参考文献：Haj-Mirzaian, A., et al. (2024). Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer: A Systematic Review and Meta-Analysis. JAMA Network Open, e244258. doi.org/10.1001/jamanetworkopen.2024.4258.
Improved MRI/MRSI for biopsy guidance of prostate cancerdoi:10.1016/S1076-6332(03)00405-7NoneELSEVIERAcademic Radiology
Prostate Cancer Update 2019: Is MRI Imaging Replacing Biopsy? Naturopathic Doctor News & ReviewTAMBURRI, PHRANQ D.
Churukanti G1, Siddiqui MM1. Prostate cancer: MRI-TRUS fusion biopsy versus 12-core systematic biopsy. Nat Rev Urol. 2015;12:369-71.G. Churukanti and M. M. Siddiqui, Prostate cancer: MRI-TRUS fusion biopsy versus 12-core systematic biopsy, Nat. Rev. Urol. 12 (2015) 369-371....
MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378:1767-77. http://dx.doi.org/10.1056/NEJMoa1801993.KASIVISVANATHAN, V., RANNIKKO, A., BORGHI, M. et. al., MRI- Targeted or Standard Biopsy for Prostate-Cancer Diagnosis, N Engl J Med 2018, pp. ...
MP74-08[68GA]PSMA PET/CT VS. MPMRI IN PATIENTS WITH SUSPICION OF PROSTATE CANCER AND PREVIOUS NEGATIVE BIOPSY: RESULTS OF THE PROSPET-BX TRIAL To compare the utility of quantitative PET/MRI, dynamic susceptibility contrast (DSC) perfusion MRI (pMRI), and PET/CT in differentiating radiation...
Multiparametric MRI (mpMRI) and MRI/transrectal-ultrasonography (TRUS)-guided fusion biopsy could improve detection of clinically significant prostate cancer in men with previous negative biopsy findings. A study published in BJU International prospectively enrolled men with elevated or rising PSA and/or...